FIJYX
Price
$30.44
Change
-$0.05 (-0.16%)
Updated
Feb 21 closing price
Net Assets
1.54B
JNGLX
Price
$71.57
Change
-$0.51 (-0.71%)
Updated
Feb 21 closing price
Net Assets
5B
Ad is loading...

FIJYX vs JNGLX

Header iconFIJYX vs JNGLX Comparison
Open Charts FIJYX vs JNGLXBanner chart's image
Fidelity Advisor Biotechnology Z
Price$30.44
Change-$0.05 (-0.16%)
VolumeN/A
Net Assets1.54B
Janus Henderson Global Life Sciences D
Price$71.57
Change-$0.51 (-0.71%)
VolumeN/A
Net Assets5B
FIJYX vs JNGLX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FIJYX vs. JNGLX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FIJYX is a Buy and JNGLX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
JNGLX has more cash in the bank: 5B vs. FIJYX (1.54B). FIJYX pays higher dividends than JNGLX: FIJYX (1.37) vs JNGLX (0.12). FIJYX was incepted earlier than JNGLX: FIJYX (6 years) vs JNGLX (26 years). FIJYX is a more actively managed with annual turnover of: 78.00 vs. JNGLX (34.00). FIJYX has a lower initial minimum investment than JNGLX: FIJYX (0) vs JNGLX (2500). JNGLX (-3.67) and FIJYX (-3.68) have marching annual gain over last year. JNGLX return over 5 years is better than : 17.54 vs. FIJYX (4.97).
FIJYXJNGLXFIJYX / JNGLX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence6 years26 years-
Gain YTD1.7045.42131%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets1.54B5B31%
Annual Yield % from dividends1.370.121,154%
Returns for 1 year-3.68-3.67100%
Returns for 3 years25.0815.97157%
Returns for 5 years4.9717.5428%
Returns for 10 yearsN/A29.25-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MGRAX44.46-0.12
-0.27%
MFS International Growth A
DBOCX23.75-0.30
-1.25%
BNY Mellon Balanced Opportunity C
PMPRX15.37-0.29
-1.85%
Principal MidCap Value I R3
TETAX13.61-0.29
-2.09%
RBC Enterprise A
GSXPX54.04-1.36
-2.45%
Goldman Sachs Small Cp Val Insghts P